Velocity Clinical Research, Gaffney

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• COPD2 trials
• Migraine2 trials
• Alzheimer disease1 trial
• Obesity1 trial
• Type 1 diabetes1 trial
• Type 2 diabetes1 trial

Phase

• Phase 33 trials
• Phase 21 trial
• Phase 2/31 trial
• Phase 41 trial

Status

• Active, not recruiting3 trials
• Recruiting2 trials
• Completed1 trial

Lead sponsor

• Pfizer2 trials
• Eli Lilly and Company1 trial
• Novo Nordisk A/S1 trial
• TriGemX Bio, Inc.1 trial
• Uniquity One (UNI)1 trial

Running trials

• Recruiting

  A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

  NCT07816367· Phase 3· TriGemX Bio, Inc.· Source

  Contact: David Erb

• Recruiting

  A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

  NCT07564414· Phase 3· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

• Recruiting

  A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

  NCT07363694· Phase 2/3· Pfizer· Source

• Active, not recruiting

  A Study to Evaluate Solrikitug in Participants With COPD (ZION)

  NCT06496620· Phase 2· Uniquity One (UNI)· Source

• Active, not recruiting

  A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)

  NCT05026866· Phase 3· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• COPD1 recruiting
• Migraine1 recruiting

Closed trials

• Completed

  Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens

  NCT05217927· Phase 4· Pfizer· Source